Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/31/2026

Diagnostic and Genetic Testing Guidelines for Fragile X‑Associated Tremor/Ataxia Syndrome (FXTAS)

1. Primary Genetic Test

  • FMR1 CGG repeat analysis is the definitive test for diagnosing FXTAS – the assay quantifies the number of CGG trinucleotide repeats in the 5′ untranslated region of the FMR1 gene located at Xq27.3. [1] [2]

2. CGG Repeat Classification and Associated Risk

CGG Repeat Range Classification Associated Clinical Risk
5‑44 Normal No risk of FXTAS. [4] [5]
45‑54 Intermediate / gray zone Rare cases of FXTAS reported; larger studies needed. [5]
55‑200 Premutation FXTAS occurs in this range. [4]
 > 200 Full mutation Causes fragile X syndrome, not FXTAS. [6] [4]

3. Age‑ and Sex‑Specific Penetrance

  • Penetrance of FXTAS increases with advancing age and larger CGG repeat size in premutation carriers. [2] [3]
  • Combined PCR and Southern blot analysis (or newer repeat‑primed PCR methods) should be used for FMR1 testing to ensure detection of both premutation and full‑mutation alleles. 6
  • Traditional PCR alone may miss full mutations in mosaic samples that span premutation and full‑mutation ranges. 6
  • Southern blot should accompany PCR to assess methylation status and identify full mutations. 6
  • Triplet repeat‑primed PCR or methylation‑specific PCR can replace routine Southern blot on every sample, improving efficiency. 6
  • Quality‑control samples representing difficult genotypes (premutations and diffuse full mutations) are essential for assay validation. 6

5. Genetic Counseling and Family Implications

  • Female premutation carriers have an approximately 20 % lifetime risk of fragile X‑associated primary ovarian insufficiency (FXPOI); risk is higher when CGG repeats exceed 80. [2] [3]
  • Premutation alleles are unstable during maternal transmission and may expand to full mutations, leading to fragile X syndrome in offspring. 2
  • Women with premutations should be offered prenatal diagnostic testing for every pregnancy. 5

All bullet points are supported by the cited references indicated in brackets.

REFERENCES